The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Accuray, Inc. | Common | 004397105 | 6,441 | 731,943 | SH | SOLE | 731,943 | 0 | 0 | ||
Acorda Therapeutics, Inc. | Common | 00484M106 | 7,610 | 225,762 | SH | SOLE | 225,762 | 0 | 0 | ||
Actavis plc | Shares | G0083B108 | 45,883 | 205,707 | SH | SOLE | 205,707 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Common | 00767E102 | 1 | 20 | SH | SOLE | 20 | 0 | 0 | ||
Aetna, Inc. | Common | 00817Y108 | 20,071 | 247,541 | SH | SOLE | 247,541 | 0 | 0 | ||
Akorn, Inc. | Common | 009728106 | 23,254 | 699,382 | SH | SOLE | 699,382 | 0 | 0 | ||
Alere, Inc. | Common | 01449J105 | 10,722 | 286,540 | SH | SOLE | 286,540 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 52,484 | 335,899 | SH | SOLE | 335,899 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 12,883 | 255,970 | SH | SOLE | 255,970 | 0 | 0 | ||
Allergan, Inc. | Common | 018490102 | 26,504 | 156,627 | SH | SOLE | 156,627 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 3,891 | 61,595 | SH | SOLE | 61,595 | 0 | 0 | ||
Amarin Corporation plc | Sponsored ADR | 023111206 | 1,769 | 1,005,000 | SH | SOLE | 1,005,000 | 0 | 0 | ||
Amgen, Inc. | Common | 031162100 | 53,212 | 449,543 | SH | SOLE | 449,543 | 0 | 0 | ||
BioDelivery Sciences International, Inc. | Common | 09060J106 | 6,054 | 501,553 | SH | SOLE | 501,553 | 0 | 0 | ||
Biogen Idec, Inc. | Common | 09062X103 | 54,859 | 173,983 | SH | SOLE | 173,983 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 26,214 | 421,384 | SH | SOLE | 421,384 | 0 | 0 | ||
bluebird bio, Inc. | Common | 09609G100 | 2,103 | 54,527 | SH | SOLE | 54,527 | 0 | 0 | ||
Bristol-Myers Squibb Co. | Common | 110122108 | 9,828 | 202,600 | SH | SOLE | 202,600 | 0 | 0 | ||
Catamaran Corporation | Common | 148887102 | 10,201 | 231,000 | SH | SOLE | 231,000 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 81,079 | 944,092 | SH | SOLE | 944,092 | 0 | 0 | ||
Celladon Corporation | Common | 15117E107 | 13,215 | 970,495 | SH | SOLE | 970,495 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 4,537 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
Clovis Oncology, Inc. | Common | 189464100 | 1,961 | 47,364 | SH | SOLE | 47,364 | 0 | 0 | ||
Cubist Pharmaceuticals, Inc. | Common | 229678107 | 18,417 | 263,772 | SH | SOLE | 263,772 | 0 | 0 | ||
Endo International PLC | Shares | G30401106 | 8,838 | 126,215 | SH | SOLE | 126,215 | 0 | 0 | ||
Epizyme Inc. | Common | 29428V104 | 2,183 | 70,162 | SH | SOLE | 70,162 | 0 | 0 | ||
Forest Laboratories, Inc. | Common | 345838106 | 10,878 | 109,875 | SH | SOLE | 109,875 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 124,756 | 1,504,712 | SH | SOLE | 1,504,712 | 0 | 0 | ||
Heron Therapeutics, Inc. | Common | 427746102 | 10,767 | 873,940 | SH | SOLE | 873,940 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 7,515 | 56,265 | SH | SOLE | 56,265 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 18,540 | 103,841 | SH | SOLE | 103,841 | 0 | 0 | ||
Impax Laboratories, Inc. | Common | 45256B101 | 10,337 | 344,683 | SH | SOLE | 344,683 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 43,359 | 768,238 | SH | SOLE | 768,238 | 0 | 0 | ||
Infinity Pharmaceuticals, Inc. | Common | 45665G303 | 8,673 | 680,746 | SH | SOLE | 680,746 | 0 | 0 | ||
IntelliPharmaCeutics International Inc. | Common | 458173101 | 5,349 | 1,404,000 | SH | SOLE | 1,404,000 | 0 | 0 | ||
InterMune, Inc. | Note 2.5% 9/15/18 | 45884XAE3 | 2,702 | 1,800,000 | PRN | SOLE | 1,800,000 | 0 | 0 | ||
Ironwood Pharmaceuticals, Inc. | Common | 46333X108 | 11,774 | 768,050 | SH | SOLE | 768,050 | 0 | 0 | ||
ishares Nasdaq Biotechnology ETF | ETF | 464287556 | 16,754 | 65,184 | SH | SOLE | 65,184 | 0 | 0 | ||
Jazz Pharmaceuticals PLC | Shares | G50871105 | 14,107 | 95,957 | SH | SOLE | 95,957 | 0 | 0 | ||
KYTHERA Biopharmaceuticals Inc. | Common | 501570105 | 1,880 | 49,000 | SH | SOLE | 49,000 | 0 | 0 | ||
Macrogenics, Inc. | Common | 556099109 | 692 | 31,857 | SH | SOLE | 31,857 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 12,637 | 67,862 | SH | SOLE | 67,862 | 0 | 0 | ||
MEI Pharma, Inc. | Common | 55279B202 | 1,546 | 243,920 | SH | SOLE | 243,920 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Note 4.50% 7/15/20 | 590328AA8 | 1,966 | 1,485,000 | PRN | SOLE | 1,485,000 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Common | 590328100 | 4,139 | 567,787 | SH | SOLE | 567,787 | 0 | 0 | ||
Molina Healthcare, Inc. | Common | 60855R100 | 9,486 | 212,541 | SH | SOLE | 212,541 | 0 | 0 | ||
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 4,270 | 353,475 | SH | SOLE | 353,475 | 0 | 0 | ||
Mylan, Inc. | Common | 628530107 | 33,628 | 652,209 | SH | SOLE | 652,209 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 11,731 | 790,490 | SH | SOLE | 790,490 | 0 | 0 | ||
NPS Pharmaceuticals, Inc. | Common | 62936P103 | 2,740 | 82,900 | SH | SOLE | 82,900 | 0 | 0 | ||
OncoGenex Pharmaceuticals, Inc. | Common | 68230A106 | 422 | 113,100 | SH | SOLE | 113,100 | 0 | 0 | ||
PerkinElmer, Inc. | Common | 714046109 | 7,752 | 165,495 | SH | SOLE | 165,495 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 9,176 | 62,952 | SH | SOLE | 62,952 | 0 | 0 | ||
Pfizer, Inc. | Common | 717081103 | 9,942 | 334,957 | SH | SOLE | 334,957 | 0 | 0 | ||
PTC Therapeutics, Inc. | Common | 69366J200 | 2,069 | 79,150 | SH | SOLE | 79,150 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 54,648 | 193,466 | SH | SOLE | 193,466 | 0 | 0 | ||
Sagent Pharmaceuticals, Inc. | Common | 786692103 | 10,466 | 404,731 | SH | SOLE | 404,731 | 0 | 0 | ||
Sangamo BioSciences, Inc. | Common | 800677106 | 1,839 | 120,400 | SH | SOLE | 120,400 | 0 | 0 | ||
Shire plc | Sponsored ADR | 82481R106 | 29,041 | 123,322 | SH | SOLE | 123,322 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | ADR | 881624209 | 16,328 | 311,476 | SH | SOLE | 311,476 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 7,040 | 59,660 | SH | SOLE | 59,660 | 0 | 0 | ||
UnitedHealth Group, Inc. | Common | 91324P102 | 6,800 | 83,186 | SH | SOLE | 83,186 | 0 | 0 | ||
Verastem, Inc. | Common | 92337C104 | 8,325 | 918,827 | SH | SOLE | 918,827 | 0 | 0 | ||
Vertex Pharmaceuticals, Inc. | Common | 92532F100 | 51,217 | 540,944 | SH | SOLE | 540,944 | 0 | 0 |